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Hepatitis B is a major public health problem worldwide that may lead to chronic 
liver diseases, cirrhosis and hepatocellular carcinoma. It is caused by hepatitis B 
virus (HBV) which is responsible for 500,000 deaths annually. The preS domain 
of HBV particularly amino acids 21-47, is believed to be involved in the initial 
step of HBV infection through attachment to hepatocyte. In order to study virus-
cell interactions, both T7 and M13 bacteriophages have been genetically 
modified to display regions of Hepatitis B surface antigens. In the present study, 
the recombinant T7 and M13 phages were used to transfect human 
hepatocarcinoma cell line HepG2. Interestingly, T7-PreS1/2 carrying the second 
half of preS1 (residues 60-108), but not T7-PreS1/1 which carried the first half of 
preS1 (residues 1-47), was demonstrated to be the most effective in transfecting 
HepG2 cells in a dose- and time-dependant manner. The DNA of phage could be 
recovered from cell lysate and confirmed by PCR whereas infectious form of 
internalized phage was measured by plaque forming assay. Under fluorescence 
microscope, internalized phage exhibited the appearance as fluorescent dots. On 
the other hand, M13-PreS carrying the preS region showed low efficiency of 
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transfection, thus suggesting that the interaction is also dependant on the valency 
of targeting ligand. Surprisingly, unmodified phages (MOI ≈ 1.25 × 105) were 
also capable of transfecting HepG2 at low efficiency and were thought to be 
taken up by nonspecific uptake. Dynamic light scattering analysis has been 
carried out to determine the thermostability of recombinant phages. The display 
of HBV surface antigen did not affect the stability of phages since no significant 
differences in thermostability were observed between control and recombinant 
phages. The ability and stability of recombinant phages to transfect HepG2 cells 
demonstrate the potential of phage displayed system as gene therapy for liver 
cancer.  
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Hepatitis B merupakan masalah utama kesihatan awam sedunia yang 
menyebabkan penyakit hati kronik, sirosis dan barah hati. Penyakit ini 
disebabkan oleh virus hepatitis B (HBV) dan menjadi punca kematian sebanyak 
500,000 setiap tahun. Kawasan liputan preS HBV terutamanya asid amino 21-47, 
dipercayai terlibat dalam jangkitan awal HBV melalui pelekatan pada hepatosit. 
Untuk mempelajari interaksi virus-sel, genetik bakteriofaj  T7 and M13 telah 
diubah-suai untuk mempamerkan kawasan-kawasan antigen permukaan Hepatitis 
B. Dalam kajian ini, faj rekombinan T7 and M13 digunakan untuk menjangkiti 
sel barah manusia HepG2. Yang menariknya, T7-PreS1/2 yang membawa 
separuh kedua preS1 (residu 60-108), dan bukannya T7-PreS1/1 yang membawa 
separuh pertama preS1 (residu 1-47), didapati paling berkesan dalam transfeksi 
sel-sel HepG2 bergantung kepada dos faj dan masa. DNA faj boleh didapati di 
dalam sel dan disahkan dengan PCR manakala faj berjangkit dalaman dapat 
dikira melalui ujian pembentukan plak. Faj dalaman dapat dilihat sebagai bintik-
bintik pendarfluor dengan mikroskop pendarfluor. Sementara itu, M13-PreS 
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yang membawa kawasan preS menunjukkan transfeksi dengan effisiensi yang 
rendah, mencadangkan bahawa perhubungan tersebut juga bergantung kepada 
valensi ligan penujuan. Yang menakjubkannya, faj (MOI ≈ 1.25 × 105) yang 
tidak diubah-suai juga berupaya menjangkiti HepG2 dengan effisiensi transfeksi 
yang rendah dan dijangka melalui mekanisma tidak spesifik. Analisis serakan 
cahaya dinamik telah dijalankan untuk menentukan kestabilan haba faj 
rekombinan. Pameran antigen permukaan HBV didapati tidak menjejaskan 
kestabilan faj memandangkan tiada perbezaan ketara diperhatikan antara 
kestabilan haba faj kawalan dan rekombinan. Oleh itu, kebolehan dan kestabilan 
faj dalam menjangkiti sel HepG2 telah menunjukkan potensi sistem pameran faj 
sebagai terapi gen untuk barah hati.  
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CHAPTER 1 
 
INTRODUCTION 
 
Hepatitis B virus (HBV) is the prototype of Hepadnaviridae, a family 
which includes related hepatitis viruses which infect woodchucks (WHV), 
ground squirrels (GSHV) and Pekin ducks (DHBV) (Summers and Mason, 
1982). Worldwide, two billion people have been infected with HBV of which 
400 million are chronically infected. Chronic infection of HBV causes 
progressive liver diseases and hepatocellular carcinoma (HCC) that responsible 
for around 500,000 deaths each year (Perz et al., 2006).   
 
To date, alpha interferon therapy can be used for treatment of chronic 
HBV infection. Nevertheless, it is ineffective in more than 50% of carriers 
(Hoofnagle and Di Bisceglie, 1997) and it is associated with several side effects 
(Torre and Tambini, 1996). Other therapy using nucleoside analogs and 
inhibitors of virus replication have led to development of drug-resistant mutants 
due to high rate of viral turn over and error-prone polymerase (Locarnini and 
Omata, 2006).  
 
A vaccine derived from inactivated hepatitis B surface antigen (HBsAg) 
purified from human plasma was first licensed in the United States, followed by 
yeast- and mammalian-derived hepatitis B vaccines which are now widely used 
(Shouval et al., 1994; Mahoney, 1999). The ultimate goal of hepatitis B 
vaccination is to control HBV-related chronic liver diseases and hepatocellular 
 1
 2
carcinoma. However, HBV with molecular variants in the ‘a’ determinant of 
HBsAg make it unsusceptible for recognition and neutralisation by anti-HBsAg 
antibodies.  
 
Gene therapy has been recognized as one of the most promising 
approaches in curing cancers (Verma and Sonia, 1997). The technology requires 
a gene delivery vehicle capable of targeting a therapeutic gene to the selected cell 
type with high efficiency without stimulating significant immune, inflammatory 
and cytotoxic responses (Michael and Curiel, 1994). Hence, the use of phage 
display systems for mammalian gene transfer is of great interest due to their 
stability, direct linkage between genotype and phenotype, inexpensive mass 
production or purification and excellent safety profile in mammalian cells 
(Larocca and Baird, 2001). By displaying targeting sequences on the phage coat, 
bacteriophage vectors which exhibit no natural tropism for mammalian cells may 
confer mammalian cell-type specific tropism through receptor-mediated 
endocytosis (RME) (Varga et al., 2000), thus offer an advantage in targeting 
treatment of cancer.  
 
In the present study, T7 and M13 phages displaying regions of HBsAg 
which are believed to be involved in infectivity and attachment site for 
hepatocytes, were used for targeting human hepatocellular carcinoma cell line 
(HepG2). Therefore, this study was aimed to examine the ability of genetically-
targeted T7 and M13 phages in delivering their genes and internalise to HepG2 
cells. The thermostability of T7 and M13 particles was also tested with dynamic 
light scattering (DLS). 
CHAPTER 2 
 
LITERATURE REVIEW 
 
2.1 Hepatitis B Virus (HBV) 
 
2.1.1 HBV Morphology 
 
Human HBV is an enveloped DNA virus grouped under the family 
Hepadnaviridae and genus Orthohepadnavirus (Ganem and Varmus, 1987). 
Internal to the envelope is the viral nucleocapsid that comprises of core proteins, 
a partially double stranded DNA genome of 3.2 kb and a polymerase protein (P) 
(Ganem, 1991). HBV has three forms of surface antigens (HBsAg): large L-
HBsAg, middle M-HBsAg and small S-HBsAg that are embedded in the 
envelope of the virion.  During HBV infection of an individual, HBsAg particles 
containing only HBsAg are produced in great abundance. These noninfectious 
particles exist as spherical and filamentous forms of 22 nm in diameter, which is 
smaller than the 42 nm infectious Dane particles or HBV virion (Dane et al., 
1970). 
 
2.1.2 Genomic Organisation and Viral Transcripts 
 
 A hepadnavirus virion contains two single-stranded linear DNA 
molecules of different sizes which paired in an overlapping fashion with breaks 
at both strands, producing a circular partially double stranded molecule. The 
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negative (−) strand is about 3200 bases long, which serves as the template for all 
viral mRNA transcription, whereas the positive (+) strand varies in length, from 
1700 to 2800 bases long. A protein, P is covalently attached to 5’ end of the (−) 
strand (Gerlich and Robinson, 1980), while the (+) strand ends in a 19-base-long 
RNA molecule. At the 5’ end of both strands, there is a pair of directly repeated 
11-base-long sequences, designated as DR1 and DR2 that play crucial role in the 
initiation of viral DNA synthesis (Lien et al., 1986; Will et al., 1987). 
 
 As shown in Figure 2.1, there are four open reading frames (ORF) 
present in the DNA, which are C, P, S and X (Wei and Tiollais, 1999). ORF C 
contains two in-frame start codons, AUGs, which encode the structural protein of 
the HBV nucleocapsid (Pasek et al., 1979), and a hydrophobic polypeptide 
bearing hepatitis B e antigen (HBeAg). Instead of incorporating into HBV 
virions, HBeAg is secreted from cells and accumulating in the serum. The ORF P 
sequence overlaps the end of ORF C region and continues nearly to the end of 
the DNA molecule. It encodes the viral polymerase which is utilised in the viral 
genomic replication as well as the protein primer molecule that is attached to the 
5’ end of (−) strand DNA (Bosch et al., 1988). Within the ORF P is the ORF S 
which occurs with three in-frame initiation codons, resulting in the synthesis of 
three related HBsAg. These proteins of 39 (L-HBsAg), 33 (M-HBsAg) and 24 
kDa (S-HBsAg) in size are found on the surface of the virion (Valenzuela et al., 
1979; Wong et al., 1985).  
 
 Although there are four ORFs in HBV genome, only three mRNAs are 
synthesized. In addition, the product of ORF X is not well understood. It appears 
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to encode possibly three trans active regulatory proteins that facilitate the 
transcription from cellular and viral promoter sequences (Seeger and Mason, 
2000). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: Transcriptional and translational map of HBV. The inner circles 
represent the rcDNA. It comprises of a complete (−) strand DNA and an 
incomplete (+) strand DNA with the reverse transcriptase and a capped RNA 
oligomer attached to its 5’ end respectively. The position of direct repeat 
sequences, DR1 and DR2, and the enhancers, EN1 and EN2 are indicated. Three 
major viral RNAs, the core (C) or pgRNA, preS (L) mRNA an S mRNA are 
depicted by the outer circle, are controlled by several internal promoters at 
different sites but are all terminated at a common 3’ end, indicated by the letters 
A. In between the outer and inner circles are the four protein-coding regions 
which include precore (PC) and core genes, polymerase gene and X gene. The 
envelope genes, L, M and S overlap with the polymerase ORF (adapted from 
Seeger and Mason, 2000).  
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2.1.3 Hepadnavirus Replication 
 
A hepadnavirus particle contains predominantly relaxed-circular DNA 
molecules (rcDNA) with a complete minus (−) strand and a partially synthesized 
plus (+) strand. A small amount of linear DNAs as a result of in situ priming is 
also found. The (−) strand is covalently attached to a protein, the viral reverse 
transcriptase at 5’ end while the (+) strand ends in a 19-base-long RNA (Voyles, 
2002).  
 
The life cycle of HBV (Figure 2.2) begins by attaching to the host cell 
membrane via its envelope proteins and the virus release its genome into the 
nucleoplasm (Lu et al., 1996; Kann et al., 2007). During initiation of infection, 
the (+) strand is elongated until both strands are of essentially equal length. Both 
the protein and RNA at the 5’ end are removed from the strands and a covalently 
closed circular DNA (cccDNA) is formed when the viral genome reaches the 
nucleus. The formation of cccDNA indicates successful initiation of infection as 
the cccDNA serves as a template for mRNA transcription (Tuttleman et al., 
1986).  
 
Replication begins with the synthesis of the pregenomic RNA (pgRNA) 
molecule which is larger than its genome (Figure 2.2), and has terminal repeats 
since same set of bases is copied twice. The pgRNA would serve as a template 
for synthesis of core (C) protein (HBcAg) and preC, viral envelope (S), viral 
polymerase (P) and X proteins (Summers and Mason, 1982). The P protein binds 
to the epsilon (ε) stem-loop structure at the 5’ end of its own mRNA template 
and initiates encapsidation into nucleocapsids that are assembled in the cytosol 
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